{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T10:55:30Z","timestamp":1788519330845,"version":"build-2803163510"},"reference-count":178,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008222","name":"The Ben and Catherine Ivy Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008222","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.canlet.2026.218373","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T17:08:26Z","timestamp":1772125706000},"page":"218373","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A longitudinal analysis of radiosensitizer development in cancer therapy"],"prefix":"10.1016","volume":"645","author":[{"suffix":"Jr.","given":"Paul T.","family":"Winnard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2322-1423","authenticated-orcid":false,"given":"Venu","family":"Raman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2026.218373_bib26","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S0140-6736(55)90589-4","article-title":"High-pressure oxygen and radiotherapy","volume":"268","author":"Churchill-Davidson","year":"1955","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2026.218373_bib27","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1259\/0007-1285-30-356-406","article-title":"Oxygenation in radiotherapy. II. Clinical application","volume":"30","author":"Churchill-Davidson","year":"1957","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.canlet.2026.218373_bib38","first-page":"215","article-title":"Hyperbaric oxygen and radiotherapy: clinical experiences","volume":"34","author":"Churchill-Davidson","year":"1968","journal-title":"Nunt. Radiol."},{"key":"10.1016\/j.canlet.2026.218373_bib39","doi-asserted-by":"crossref","DOI":"10.1139\/y67-005","article-title":"Effects of breathing gases containing oxygen and carbon dioxide at 1 and 3 atmospheres pressure on blood flow and oxygenation of tumors","volume":"45","author":"Kruuv","year":"1967","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.canlet.2026.218373_bib41","article-title":"Clinical trial with atmospheric oxygen breathing during radiotherapy of cancer of cervix","volume":"22","author":"Bergsjo","year":"1968","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.canlet.2026.218373_bib42","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1148\/106.3.663","article-title":"Factors affecting hypoxic kht tumor-cells in mice breathing O2, O2 + CO2, or hyperbaric-oxygen with or without anesthesia","volume":"106","author":"Milne","year":"1973","journal-title":"Radiology"},{"key":"10.1016\/j.canlet.2026.218373_bib43","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1152\/jappl.1958.13.1.61","article-title":"Effects of oxygen breathing on tumor oxygen measured polarographically","volume":"13","author":"Urbach","year":"1958","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.canlet.2026.218373_bib44","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1259\/0007-1285-36-430-749","article-title":"The effect of oxygen on the response of spontaneous tumours in mice to radiotherapy","volume":"36","author":"Dusault","year":"1963","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.canlet.2026.218373_bib45","first-page":"688","article-title":"The combination of oxygen and optimum fractionation in radiation therapy of adenocarcinoma","volume":"82","author":"Dusault","year":"1959","journal-title":"Am. J. Roentgenol. Radium Ther. Nucl. Med."},{"key":"10.1016\/j.canlet.2026.218373_bib46","article-title":"Effect of breathing 5 percent carbon dioxide and 95 percent oxygen at atmospheric pressure on tumour radiocurability","volume":"4","author":"Inch","year":"1966","journal-title":"Acta Radiol. Ther. Phys. Biol."},{"key":"10.1016\/j.canlet.2026.218373_bib47","doi-asserted-by":"crossref","DOI":"10.1002\/1097-0142(1967)20:1<51::AID-CNCR2820200108>3.0.CO;2-D","article-title":"Blood flow and oxygenation of tumors in mice .i. effects of breathing gases containing carbon dioxide at atmospheric pressure","volume":"20","author":"Kruuv","year":"1967","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2026.218373_bib48","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1002\/1097-0142(196510)18:10<1244::AID-CNCR2820181005>3.0.CO;2-F","article-title":"Regional oxygenation in the diagnosis and management of intra-abdominal and retroperitoneal neoplasms","volume":"18","author":"Aronoff","year":"1965","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2026.218373_bib49","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1177\/000331976501600203","article-title":"Peripheral blood changes in humans and experimental animals following infusion of hydrogen peroxide into carotid artery","volume":"16","author":"Finney","year":"1965","journal-title":"Angiology"},{"key":"10.1016\/j.canlet.2026.218373_bib50","first-page":"546","article-title":"Regional intra-arterial hydrogen peroxide infusion and irradiation in the treatment of head and neck malignancies: a progress report","volume":"67","author":"Mallams","year":"1963","journal-title":"Trans. Am. Acad. Ophthalmol. Otolaryngol."},{"key":"10.1016\/j.canlet.2026.218373_bib51","first-page":"137","article-title":"Regional oxygenation and irradiation in the treatment of malignant tumors","volume":"10","author":"Mallams","year":"1965","journal-title":"Prog. Clin. Cancer"},{"key":"10.1016\/j.canlet.2026.218373_bib52","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1001\/archotol.79.2.63","article-title":"Regional oxygenation and irradiation: head and neck","volume":"79","author":"Mallams","year":"1964","journal-title":"Arch. Otolaryngol."},{"key":"10.1016\/j.canlet.2026.218373_bib53","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/00007611-196203000-00002","article-title":"The use of hydrogen peroxide as a source of oxygen in a regional intra-arterial infusion system","volume":"55","author":"Mallams","year":"1962","journal-title":"South. Med. J."},{"key":"10.1016\/j.canlet.2026.218373_bib54","first-page":"191","article-title":"Technique and results of radiotherapy aided by arterial infusion of hydrogen peroxide","volume":"34","author":"Whittle","year":"1968","journal-title":"Nunt. Radiol."},{"key":"10.1016\/j.canlet.2026.218373_bib55","doi-asserted-by":"crossref","DOI":"10.1152\/jappl.1963.18.3.492","article-title":"Response to high pressure oxygen of conscious volunteers and patients","volume":"18","author":"Foster","year":"1963","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.canlet.2026.218373_bib56","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1113\/jphysiol.1925.sp002254","article-title":"Tissue oxygen-tension with special reference to tetany and convulsions","volume":"60","author":"Campbell","year":"1925","journal-title":"Journal of Physiology-London"},{"key":"10.1016\/j.canlet.2026.218373_bib57","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0140-6736(01)03138-5","article-title":"Oxygen convulsions","volume":"1","author":"Campbell","year":"1934","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2026.218373_bib58","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1148\/93.5.1149","article-title":"Clinical hybaroxic radiotherapy after five years","volume":"93","author":"Wildermuth","year":"1969","journal-title":"Radiology"},{"key":"10.1016\/j.canlet.2026.218373_bib59","first-page":"651","article-title":"Experience with hyperbaric oxygenation in clinical radiotherapy","volume":"93","author":"Atkins","year":"1965","journal-title":"Am. J. Roentgenol. Radium Ther. Nucl. Med."},{"key":"10.1016\/j.canlet.2026.218373_bib60","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/1097-0142(196810)22:4<809::AID-CNCR2820220418>3.0.CO;2-N","article-title":"Application of radiobiologic principles to radiation therapy","volume":"22","author":"Suit","year":"1968","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2026.218373_bib61","doi-asserted-by":"crossref","first-page":"760","DOI":"10.2214\/ajr.96.3.760","article-title":"Results from tourniquet anoxia and hyperbaric oxygen techniques combined with megavoltage treatment of sarcomas of bone and soft tissues","volume":"96","author":"van den Brenk","year":"1966","journal-title":"Am. J. Roentgenol. Radium Ther. Nucl. Med."},{"key":"10.1016\/j.canlet.2026.218373_bib83","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/oxfordjournals.bmb.a070956","article-title":"Chemical radiosensitization of hypoxic cells","volume":"29","author":"Adams","year":"1973","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.canlet.2026.218373_bib84","doi-asserted-by":"crossref","first-page":"108","DOI":"10.2307\/3574010","article-title":"Electron affinic sensitization .5. radiosensitization of hypoxic bacteria and mammalian-cells invitro by some nitroimidazoles and nitropyrazoles","volume":"60","author":"Asquith","year":"1974","journal-title":"Radiat. Res."},{"key":"10.1016\/j.canlet.2026.218373_bib85","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0360-3016(90)90401-5","article-title":"Studies on high-grade cerebral gliomas","volume":"18","author":"Bleehen","year":"1990","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.canlet.2026.218373_bib86","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0167-8140(85)80015-3","article-title":"Chemical sensitizers for hypoxic cells - a decade of experience in clinical radiotherapy","volume":"3","author":"Dische","year":"1985","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.canlet.2026.218373_bib87","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0936-6555(05)80448-0","article-title":"Thirty years of medical research council randomized trials in solid tumours","volume":"9","author":"Machin","year":"1997","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218373_bib88","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1080\/02841860310014408","article-title":"A systematic overview of radiation therapy effects in urinary bladder cancer","volume":"42","author":"Widmark","year":"2003","journal-title":"Acta Oncol."},{"key":"10.1016\/j.canlet.2026.218373_bib93","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2307\/3578516","article-title":"Redox, radiation, and reductive bioactivation","volume":"132","author":"Adams","year":"1992","journal-title":"Radiat. Res."},{"key":"10.1016\/j.canlet.2026.218373_bib94","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/bjc.1993.220","article-title":"SR-4233 (tirapazamine) - a new anticancer drug exploiting hypoxia in solid tumors","volume":"67","author":"Brown","year":"1993","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2026.218373_bib96","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1517\/17425255.2012.730518","article-title":"Is there a role for tirapazamine in the treatment of cervical cancer?","volume":"8","author":"Ghatage","year":"2012","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.canlet.2026.218373_bib97","volume":"33","author":"Guise","year":"2014"},{"key":"10.1016\/j.canlet.2026.218373_bib98","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.ijrobp.2017.03.024","article-title":"Clinical advances of hypoxia-activated prodrugs in combination with radiation therapy","volume":"98","author":"Mistry","year":"2017","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.canlet.2026.218373_bib101","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2307\/3574443","article-title":"Radiosensitization of hypoxic cells of an invitro tumor model by respiratory inhibitors","volume":"69","author":"Durand","year":"1977","journal-title":"Radiat. Res."},{"key":"10.1016\/j.canlet.2026.218373_bib102","first-page":"52","article-title":"Evaluation of the effect of metformin as a radiosensitiser in solid tumours: a systematic review","author":"del Portillo","year":"2025","journal-title":"Clin. Transl. Radiat. Oncol."},{"key":"10.1016\/j.canlet.2026.218373_bib103","doi-asserted-by":"crossref","DOI":"10.1002\/1097-0142(196801)21:1<58::AID-CNCR2820210110>3.0.CO;2-5","article-title":"Mechanisms of action of radiotherapy and chemotherapeutic adjuvants - a review","volume":"21","author":"Vermund","year":"1968","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2026.218373_bib105","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0305-7372(74)80008-3","article-title":"Clinical use of radiation sensitizing agents","volume":"1","author":"Goffinet","year":"1974","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.canlet.2026.218373_bib106","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00066-022-01942-1","article-title":"The use of radiosensitizing agents in the therapy of glioblastoma multiforme-a comprehensive review","volume":"198","author":"Pepper","year":"2022","journal-title":"Strahlenther. Onkol."},{"key":"10.1016\/j.canlet.2026.218373_bib108","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14194874","article-title":"Targeting the DNA damage response and DNA repair pathways to enhance radiosensitivity in colorectal cancer","volume":"14","author":"Deng","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2026.218373_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216440","article-title":"The AEG-1-USP10-PARP1 axis confers radioresistance in esophageal squamous cell carcinoma via facilitating homologous recombination-dependent DNA damage repair","volume":"577","author":"Zhao","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218373_bib174","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217757","article-title":"WDR11-DT enhances radiosensitivity via promoting PARP1 degradation and homologous recombination deficiency","volume":"625","author":"Yang","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218373_bib1","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/053274b0","article-title":"On a new kind of rays","volume":"53","author":"Rontgen","year":"1896","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218373_bib2","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1136\/bmj.1.1838.748","article-title":"Report on the application of the new photography to medicine and surgery","volume":"1","author":"Rowland","year":"1896","journal-title":"Br. Med. J."},{"key":"10.1016\/j.canlet.2026.218373_bib3","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.ijrobp.2016.07.019","article-title":"Victor despeignes, the fprgotten pioneer of radiation oncology","volume":"96","author":"Foray","year":"2016","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.canlet.2026.218373_bib4","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1148\/radiographics.9.6.2685937","article-title":"A sketch of the technical history of radiology from 1896 to 1920","volume":"9","author":"Feldman","year":"1989","journal-title":"Radiographics"},{"key":"10.1016\/j.canlet.2026.218373_bib5","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0167-8140(88)90015-1","article-title":"Regaud lecture perspectives on the history of radiotherapy","volume":"12","author":"Fletcher","year":"1988","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.canlet.2026.218373_bib6","first-page":"469","article-title":"Modification of hypoxia from Gottwald Schwarz to nicotinamide. Have we learned the lesson?","author":"Overgaard","year":"1995","journal-title":"5th International Meeting on Progress in Radio-Oncology (ICRO\/OGRO 5) Salzburg, Austria"},{"key":"10.1016\/j.canlet.2026.218373_bib7","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1001\/jama.1949.02900410021006","article-title":"Roentgentherapy in cancer of the hypopharynx","volume":"140","author":"Baclesse","year":"1949","journal-title":"JAMA, J. Am. Med. Assoc."},{"key":"10.1016\/j.canlet.2026.218373_bib8","first-page":"128","article-title":"Clinical experience with ultra-fractionated roentgen therapy","volume":"1","author":"Baclesse","year":"1958","journal-title":"Progress in Radiation Therapy"},{"key":"10.1016\/j.canlet.2026.218373_bib9","first-page":"313","article-title":"Roentgen therapy of epitheliomas of the tonsillar region, hypopharynx and larynx from 1920 to 1926","volume":"28","author":"Coutard","year":"1932","journal-title":"Am. J. Roentgenol. Radium Ther."},{"key":"10.1016\/j.canlet.2026.218373_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0140-6736(00)90085-0","article-title":"Principles of X ray therapy of malignant diseases","volume":"2","author":"Coutard","year":"1934","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2026.218373_bib11","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/00000658-193710000-00010","article-title":"The results and methods of treatment of cancer by radiation","volume":"106","author":"Coutard","year":"1937","journal-title":"Ann. Surg."},{"key":"10.1016\/j.canlet.2026.218373_bib12","first-page":"293","article-title":"Roentgen diagnosis during the course of roentgen therapy of epitheliomas of the larynx and hypopharynx","volume":"28","author":"Coutard","year":"1932","journal-title":"Am. J. Roentgenol. Radium Ther."},{"key":"10.1016\/j.canlet.2026.218373_bib13","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3109\/00016923009136626","article-title":"Significance of the time factor in radium radiation - studies on cancer mice","volume":"11","author":"Juul","year":"1930","journal-title":"Acta Radiol."},{"key":"10.1016\/j.canlet.2026.218373_bib14","first-page":"191","article-title":"Roentgen dose fraction for varying periodicities","volume":"38","author":"Meyer","year":"1942","journal-title":"Radiation"},{"key":"10.1016\/j.canlet.2026.218373_bib15","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0140-6736(00)80928-9","article-title":"A method of spacing radiation in the treatment of tumours","volume":"228","author":"Mottram","year":"1936","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canlet.2026.218373_bib16","first-page":"289","article-title":"The use of gas mixtures in cancer therapy","volume":"6","author":"Campbell","year":"1931","journal-title":"Cancer Rev."},{"key":"10.1016\/j.canlet.2026.218373_bib17","first-page":"275","article-title":"Experiments on the radiation of tumours. - with special reference to their blood supply","volume":"1927","author":"Mottram","year":"1927","journal-title":"Br. Med. J. (Pract. Obs. Ed.)"},{"key":"10.1016\/j.canlet.2026.218373_bib18","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S0140-6736(00)84700-5","article-title":"Action of radiation on blood-supply of tumours","volume":"2","author":"Mottram","year":"1928","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2026.218373_bib19","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/bjs.1800197509","article-title":"On the effect of an\u00e6mia on the reactions of the skin and of tumours to radium exposure","volume":"19","author":"Mottram","year":"1932","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.canlet.2026.218373_bib20","first-page":"231","article-title":"The drop in sensitivity to X-rays in newborn mice in a state of asphyxia","volume":"215","author":"Lacassagne","year":"1942","journal-title":"Comptes Rendus Hebdomadaires Des Seances De L Academie Des Sciences"},{"key":"10.1016\/j.canlet.2026.218373_bib21","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1259\/0007-1285-30-356-403","article-title":"Oxygenation in radiotherapy. I. Radiobiological considerations","volume":"30","author":"Gray","year":"1957","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.canlet.2026.218373_bib22","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1259\/0007-1285-26-312-638","article-title":"The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy","volume":"26","author":"Gray","year":"1953","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.canlet.2026.218373_bib23","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/bjc.1955.55","article-title":"The histological structure of some human lung cancers and the possible implications for radiotherapy","volume":"9","author":"Thomlinson","year":"1955","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2026.218373_bib24","first-page":"107","article-title":"Studies on the blood supply of tumors in man .3. vascular patterns of the liver by hepatic arteriography in vivo","volume":"12","author":"Bierman","year":"1951","journal-title":"Jnci-Journal of the National Cancer Institute"},{"key":"10.1016\/j.canlet.2026.218373_bib25","first-page":"701","article-title":"Studies on the blood supply of tumors in man .4. the increased oxygen content of venous blood draining neoplasms","volume":"12","author":"Bierman","year":"1952","journal-title":"Jnci-Journal of the National Cancer Institute"},{"key":"10.1016\/j.canlet.2026.218373_bib28","first-page":"351","article-title":"Clinical trials of tetra-sodium 2-METHYL-1 4-NAPHTHOHYDROQUINONE diphosphate","volume":"2","author":"Mitchell","year":"1948"},{"key":"10.1016\/j.canlet.2026.218373_bib29","first-page":"431","article-title":"Laboratory studies and clinical radiotherapeutic trials of some chemical radio-sensitisers","volume":"116","author":"Mitchell","year":"1954","journal-title":"Acta Radiol."},{"key":"10.1016\/j.canlet.2026.218373_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/160098a0","article-title":"Combination of some effects of x-radiation and a synthetic vitamin-k substitute","volume":"160","author":"Mitchell","year":"1947","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218373_bib31","article-title":"Experiments on the mechanism of action of tetrasodium 2 - methyl - 1 4 - naphthohydroquinone diphosphate as a mitotic inhibitor and radiosensitiser, using the technique of tissue culture - relation between cytological effects and chemical constitution","volume":"6","author":"Mitchell","year":"1952","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2026.218373_bib32","doi-asserted-by":"crossref","DOI":"10.1084\/jem.103.5.653","article-title":"Action of x-rays on Mammalian cells","volume":"103","author":"Puck","year":"1956","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2026.218373_bib33","article-title":"Effect of oxygen on impairment of proliferative capacity of human cells in culture by ionizing radiations of different let","volume":"10","author":"Barendsen","year":"1966","journal-title":"Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med."},{"key":"10.1016\/j.canlet.2026.218373_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/2021190a0","article-title":"Recovery of hypoxic Mammalian cells from sub-lethal x-ray damage","volume":"202","author":"Elkind","year":"1964","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218373_bib35","doi-asserted-by":"crossref","DOI":"10.1259\/0007-1285-42-504-914","article-title":"Effect of oxygen on cellular survival and recovery after radiation","volume":"42","author":"Littbrand","year":"1969","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.canlet.2026.218373_bib36","article-title":"Effect of oxygen on dna single-strand breaks produced by ionizing-radiation in mammalian-cells","volume":"21","author":"Palcic","year":"1972","journal-title":"Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med."},{"key":"10.1016\/j.canlet.2026.218373_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/203742a0","article-title":"Variation of relative sensitivity of closely related neoplastic cell lines irradiated in culture in presence or absence of oxygen","volume":"203","author":"Revesz","year":"1964","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218373_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13081804","article-title":"Evofosfamide is effective against pediatric aggressive glioma cell lines in hypoxic conditions and potentiates the effect of cytotoxic chemotherapy and ionizing radiations","volume":"13","author":"Bailleul","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2026.218373_bib62","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11060-018-03021-x","article-title":"Use of hyperbaric oxygen therapy in pediatric neuro-oncology: a single institutional experience","volume":"141","author":"Aghajan","year":"2019","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.canlet.2026.218373_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.886603","article-title":"Hyperbaric oxygen therapy as a complementary treatment in Glioblastoma-A scoping review","volume":"13","author":"Alpuim Costa","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.canlet.2026.218373_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.643469","article-title":"Role of hyperbaric oxygenation plus hypofractionated stereotactic radiotherapy in recurrent high-grade glioma","volume":"11","author":"Arpa","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2026.218373_bib65","doi-asserted-by":"crossref","first-page":"420","DOI":"10.4103\/mgr.MEDGASRES-D-24-00096","article-title":"Hyperbaric oxygen therapy as an adjunt treatment for glioma and brain metastasis: a literature review","volume":"15","author":"Cai","year":"2025","journal-title":"Med. Gas Res."},{"key":"10.1016\/j.canlet.2026.218373_bib66","doi-asserted-by":"crossref","DOI":"10.3892\/ol.2024.14716","article-title":"Hyperbaric oxygen therapy enhances restoration of physical functional in patients with recurrent glioma: a case report","volume":"28","author":"Cai","year":"2024","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.canlet.2026.218373_bib67","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1007\/s12094-020-02513-5","article-title":"Hyperbaric oxygen and radiation therapy: a review","volume":"23","author":"Fernandez","year":"2021","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.canlet.2026.218373_bib68","series-title":"Medical Oncology","first-page":"33","article-title":"Hyperbaric oxygen as an adjunctive therapy in treatment of malignancies, including brain tumours","author":"Stepien","year":"2016"},{"key":"10.1016\/j.canlet.2026.218373_bib69","first-page":"465","article-title":"Therapeutic effect of combined hyperbaric oxygen and radiation therapy for single brain metastasis and its influence on osteopontin and MMP-9","volume":"17","author":"Tao","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.canlet.2026.218373_bib70","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/archotol.1967.00760040153005","article-title":"Hydrogen peroxide and irradiation of tumors","volume":"85","author":"Chasin","year":"1967","journal-title":"Arch. Otolaryngol."},{"key":"10.1016\/j.canlet.2026.218373_bib71","first-page":"639","article-title":"Oxygenation in radiotherapy of malignant disease of the upper air passages. Experiences with hydrogen peroxide perfusion in radiotherapy for cancer of the head and neck","volume":"57","author":"Jones","year":"1964","journal-title":"Proc. Roy. Soc. Med."},{"key":"10.1016\/j.canlet.2026.218373_bib72","doi-asserted-by":"crossref","DOI":"10.3390\/cancers8040043","volume":"8","author":"Hayashi","year":"2016","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2026.218373_bib73","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.ijrobp.2020.06.022","article-title":"Intratumoral hydrogen peroxide with radiation therapy in locally advanced breast cancer: results from a phase 1 clinical trial","volume":"108","author":"Nimalasena","year":"2020","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.canlet.2026.218373_bib74","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3892\/ijo_00000186","article-title":"Phase I study of a new radiosensitizer containing hydrogen peroxide and sodium hyaluronate for topical tumor injection: a new enzyme-targeting radiosensitization treatment, Kochi Oxydol-Radiation therapy for unresectable carcinomas, type II (KORTUC II)","volume":"34","author":"Ogawa","year":"2009","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.canlet.2026.218373_bib75","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3892\/ol.2023.13964","article-title":"KORTUC, a novel hydrogen peroxide-based radiosensitizer for the enhancement of brachytherapy in patients with unresectable recurrent uterine cervical cancer","volume":"26","author":"Shimbo","year":"2023","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.canlet.2026.218373_bib76","volume":"8","author":"Yaogawa","year":"2016","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2026.218373_bib77","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/0360-3016(77)90189-4","article-title":"Dose fractionation studies with a murine sarcoma under conditions of air or carbogen (95-percent o-2+5-percent co2) breathing","volume":"2","author":"Hill","year":"1977","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.canlet.2026.218373_bib78","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0167-8140(91)90190-R","article-title":"Radiosensitization with normobaric oxygen and carbogen","volume":"20","author":"Rojas","year":"1991","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.canlet.2026.218373_bib79","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1016\/0360-3016(79)90946-5","article-title":"Carbogen breathing during radiation-therapy - radiation-therapy oncology group-study","volume":"5","author":"Rubin","year":"1979","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.canlet.2026.218373_bib80","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/0360-3016(77)90188-2","article-title":"Importance of pre-irradiation breathing times of oxygen and carbogen (5-percent co2 - 95-Percent o-2) on invivo radiation response of a murine sarcoma","volume":"2","author":"Siemann","year":"1977","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.canlet.2026.218373_bib81","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S1053-4296(96)80032-4","article-title":"Modification of hypoxia-induced radioresistance in tumors by the use of oxygen and sensitizers","volume":"6","author":"Overgaard","year":"1996","journal-title":"Semin. Radiat. Oncol."},{"key":"10.1016\/j.canlet.2026.218373_bib82","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.ijrobp.2021.03.001","article-title":"Long-term outcomes of radical radiation therapy with hypoxia modification with biomarker discovery for stratification: 10-year update of the BCON (Bladder carbogen nicotinamide) phase 3 randomized trial (ISRCTN45938399)","volume":"110","author":"Song","year":"2021","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.canlet.2026.218373_bib89","first-page":"397","article-title":"Hypoxic sensitizer and cytotoxin for head and neck cancer","volume":"25","author":"Lee","year":"1996","journal-title":"Ann. Acad. Med. Singapore"},{"key":"10.1016\/j.canlet.2026.218373_bib90","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20170915","article-title":"Nitroimidazoles as hypoxic cell radiosensitizers and hypoxia probes: misonidazole, myths and mistakes","volume":"92","author":"Wardman","year":"2018","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.canlet.2026.218373_bib91","first-page":"208","article-title":"DAHANCA19: a randomized phase III study of primary curative (chemo)-radiotherapy and the EGFR-Inhibitor zalutumumab for squamous cell carcinoma of the head and neck","author":"Eriksen","year":"2025","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.canlet.2026.218373_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.111227","article-title":"An international placebo-controlled randomized multicenter trial of nimorazole with accelerated chemo-radiotherapy for locally advanced HPV-Negative squamous cell carcinoma of the head and neck (HNSCC)","volume":"214","author":"Gr\u00e9goire","year":"2026","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.canlet.2026.218373_bib175","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3390\/encyclopedia5010038","article-title":"Fundamentals of water radiolysis","volume":"5","author":"Jay-Gerin","year":"2025","journal-title":"Encyclopedia"},{"key":"10.1016\/j.canlet.2026.218373_bib150","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20130676","article-title":"Defining normoxia, physoxia and hypoxia in tumours-implications for treatment response","volume":"87","author":"McKeown","year":"2014","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.canlet.2026.218373_bib176","first-page":"177","article-title":"The role of DNA damage induced by low\/high dose ionizing radiation in cell carcinogenesis","volume":"6","author":"Jia","year":"2024","journal-title":"Exploratory Research and Hypothesis in Medicine"},{"key":"10.1016\/j.canlet.2026.218373_bib177","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094642","article-title":"The chemistry of reactive oxygen species (ROS) revisited: outlining their role in biological macromolecules (DNA, lipids and proteins) and induced pathologies","volume":"22","author":"Juan","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2026.218373_bib178","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.celrep.2018.03.076","article-title":"Genomic and molecular landscape of DNA damage repair deficiency across the cancer genome Atlas","volume":"23","author":"Knijnenburg","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2026.218373_bib95","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1517\/13543784.9.12.2889","article-title":"Tirapazamine: a bioreductive anticancer drug that exploits tumour hypoxia","volume":"9","author":"Denny","year":"2000","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.canlet.2026.218373_bib99","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1053\/sonc.2002.31531","article-title":"Tirapazamine: prototype for a novel class of therapeutic agents targeting tumor hypoxia","volume":"29","author":"Gandara","year":"2002","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.canlet.2026.218373_bib100","doi-asserted-by":"crossref","first-page":"9097","DOI":"10.1200\/JCO.2005.01.3771","article-title":"Phase III trial of paclitaxel plus carboplatin with or without tirapazamine in advanced non-small-cell lung cancer: Southwest oncology group trial S0003","volume":"23","author":"Williamson","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218373_bib104","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/BF02149952","article-title":"Histological changes produced by large doses of tetra-sodium 2-methyl-1-4-naphthohydroquinone diphosphate in some human tumours","volume":"5","author":"Mitchell","year":"1949","journal-title":"Experientia"},{"key":"10.1016\/j.canlet.2026.218373_bib132","doi-asserted-by":"crossref","first-page":"648","DOI":"10.15252\/emmm.201404368","article-title":"Targeting DDX3 with a small molecule inhibitor for lung cancer therapy","volume":"7","author":"Bol","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.canlet.2026.218373_bib107","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1593\/neo.06823","article-title":"Oncogenic K-Ras signals through epidermal growth factor receptor and wild-type H-Ras to promote radiation survival in pancreatic and colorectal carcinoma cells","volume":"9","author":"Cengel","year":"2007","journal-title":"Neoplasia"},{"key":"10.1016\/j.canlet.2026.218373_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217757","article-title":"WDR11-DT enhances radiosensitivity via promoting PARP1 degradation and homologous recombination deficiency","volume":"625","author":"Yang","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218373_bib111","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.semradonc.2021.09.005","article-title":"Radiotherapy-Poly(ADP-ribose) polymerase inhibitor combinations: progress to date","volume":"32","author":"Derby","year":"2022","journal-title":"Semin. Radiat. Oncol."},{"key":"10.1016\/j.canlet.2026.218373_bib112","article-title":"Pharmacologic ascorbate radiosensitizes pancreatic cancer but radioprotects normal tissue: the role of oxidative stress-induced lipid peroxidation","volume":"13","author":"Chen","year":"2024","journal-title":"Antioxidants"},{"key":"10.1016\/j.canlet.2026.218373_bib113","doi-asserted-by":"crossref","first-page":"13604","DOI":"10.1073\/pnas.0506390102","article-title":"Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues","volume":"102","author":"Chen","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2026.218373_bib114","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.redox.2016.10.010","article-title":"Tumor cells have decreased ability to metabolize H2O2: implications for pharmacological ascorbate in cancer therapy","volume":"10","author":"Doskey","year":"2016","journal-title":"Redox Biol."},{"key":"10.1016\/j.canlet.2026.218373_bib115","doi-asserted-by":"crossref","first-page":"6838","DOI":"10.1158\/0008-5472.CAN-18-1680","article-title":"Pharmacologic ascorbate reduces radiation-induced normal tissue toxicity and enhances tumor radiosensitization in pancreatic cancer","volume":"78","author":"Alexander","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218373_bib116","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1158\/0008-5472.CAN-14-1707","article-title":"Pharmacological ascorbate radiosensitizes pancreatic cancer","volume":"75","author":"Du","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218373_bib117","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.canrad.2016.02.008","article-title":"Radiation-enhancing effect of sodium glycididazole in patients suffering from non-small cell lung cancer with multiple brain metastases: a randomized, placebo-controlled study","volume":"20","author":"Zeng","year":"2016","journal-title":"Cancer Radiother."},{"key":"10.1016\/j.canlet.2026.218373_bib118","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0003-9861(83)90272-2","article-title":"Action of the anti-tumor and anti-spermogenic agent lonidamine on electron-transport in ehrlich ascites tumor mitochondria","volume":"226","author":"Floridi","year":"1983","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.canlet.2026.218373_bib119","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.bbcan.2016.08.001","article-title":"Mechanism of antineoplastic activity of lonidamine","volume":"1866","author":"Nath","year":"2016","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.canlet.2026.218373_bib120","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15041302","article-title":"Improved Tumor control following radiosensitization with ultrasound-sensitive oxygen microbubbles and Tumor mitochondrial respiration inhibitors in a preclinical model of head and neck cancer","volume":"15","author":"Lacerda","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.canlet.2026.218373_bib121","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12308","article-title":"The anti-malarial atovaquone increases radiosensitivity by alleviating tumour hypoxia","volume":"7","author":"Ashton","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218373_bib122","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-26199-7","article-title":"Timing of hypoxia PET\/CT imaging after 18F-fluoromisonidazole injection in non-small cell lung cancer patients","volume":"12","author":"Bourigault","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2026.218373_bib123","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-025-02160-9","article-title":"Atovaquone-induced activation of the PERK\/eIF2\u03b1 signaling axis mitigates metabolic radiosensitisation","volume":"23","author":"Feng","year":"2025","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.canlet.2026.218373_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.111033","article-title":"Non-cisplatin concurrent agents plus definitive radiotherapy for locally advanced head and neck cancer: a network meta-analysis of randomized studies","volume":"210","author":"Petrelli","year":"2025","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.canlet.2026.218373_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217320","article-title":"Telaglenastat as an alternative to cisplatin as a radiosensitizer in the treatment of head and neck squamous cell carcinoma","volume":"606","author":"Korns","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218373_bib126","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.218033","article-title":"Aurora kinase A inhibition as a synthetic lethality strategy in ARID1A-mutated gastroenteropancreatic neuroendocrine carcinoma","volume":"634","author":"Urbanova","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218373_bib127","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aat1719","article-title":"The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models","volume":"4","author":"Durant","year":"2018","journal-title":"Sci. Adv."},{"key":"10.1016\/j.canlet.2026.218373_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.dmd.2025.100107","article-title":"Achieving human brain exposure with the oral ataxia-telangiectasia mutated kinase inhibitor AZD1390, a substrate of aldehyde oxidase","volume":"53","author":"Colclough","year":"2025","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.canlet.2026.218373_bib129","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1021\/acs.jmedchem.3c02277","article-title":"Identification of novel, selective Ataxia-Telangiectasia mutated kinase inhibitors with the ability to penetrate the blood-brain barrier: the discovery of AZD1390","volume":"67","author":"Pike","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.canlet.2026.218373_bib130","doi-asserted-by":"crossref","first-page":"4492","DOI":"10.1158\/1078-0432.CCR-23-0290","article-title":"ATM-inhibitor AZD1390 is a radiosensitizer for breast cancer CNS metastasis","volume":"29","author":"Tew","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218373_bib131","doi-asserted-by":"crossref","first-page":"ziaf129","DOI":"10.1093\/jbmrpl\/ziaf129","article-title":"ATM inhibition increases the anti-tumor efficacy of radium-223 (Ra-223) against prostate cancer bone metastasis in preclinical models","volume":"9","author":"Lefley","year":"2025","journal-title":"JBMR Plus"},{"key":"10.1016\/j.canlet.2026.218373_bib133","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/onc.2017.308","article-title":"Targeting mitochondrial translation by inhibiting DDX3: a novel radiosensitization strategy for cancer treatment","volume":"37","author":"Heerma van Voss","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2026.218373_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.108925","article-title":"RNA helicase DDX3 regulates RAD51 localization and DNA damage repair in ewing sarcoma","volume":"27","author":"Randolph","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.canlet.2026.218373_bib135","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.tranon.2018.09.002","article-title":"Targeting DDX3 in medulloblastoma using the small molecule inhibitor RK-33","volume":"12","author":"Tantravedi","year":"2019","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.canlet.2026.218373_bib136","doi-asserted-by":"crossref","first-page":"6340","DOI":"10.1158\/0008-5472.CAN-16-0440","article-title":"RK-33 radiosensitizes prostate cancer cells by blocking the RNA helicase DDX3","volume":"76","author":"Xie","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218373_bib137","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2024.101758","article-title":"Free fatty acid-induced DDX3 inhibits autophagy via miR-141 upregulation in diet-induced MASLD mice model system","volume":"30","author":"Hossain","year":"2025","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.canlet.2026.218373_bib138","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/jvh.13799","article-title":"DDX3-mediated miR-34 expression inhibits autophagy and HBV replication in hepatic cells","volume":"30","author":"Mishra","year":"2023","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.canlet.2026.218373_bib139","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217260","article-title":"Targeting RNA helicase DDX3X with a small molecule inhibitor for breast cancer bone metastasis treatment","volume":"604","author":"Winnard","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218373_bib140","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.167566","article-title":"The mRNA-binding protein DDX3 mediates TGF-?1 upregulation of translation and promotes pulmonary fibrosis","volume":"8","author":"Chen","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.canlet.2026.218373_bib141","first-page":"15","article-title":"Understanding the role of radio-sensitizing nanoparticles in enhancing pathologic response in soft tissue sarcomas","author":"Stergioula","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2026.218373_bib142","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1080\/14796694.2025.2496131","article-title":"Nanoray-312: phase III study of NBTXR3 + radiotherapy +\/- cetuximab in elderly, platinum-ineligible locally advanced HNSCC","volume":"21","author":"Le Tourneau","year":"2025","journal-title":"Future Oncol."},{"key":"10.1016\/j.canlet.2026.218373_bib143","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.radonc.2012.09.015","article-title":"FAZA PET\/CT hypoxia imaging in patients with squamous cell carcinoma of the head and neck treated with radiotherapy: results from the DAHANCA 24 trial","volume":"105","author":"Mortensen","year":"2012","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.canlet.2026.218373_bib144","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.radonc.2005.06.038","article-title":"Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study","volume":"77","author":"Nordsmark","year":"2005","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.canlet.2026.218373_bib145","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0167-8140(00)00223-1","article-title":"A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy","volume":"57","author":"Nordsmark","year":"2000","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.canlet.2026.218373_bib146","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.3109\/0284186X.2016.1167959","article-title":"Validation of a 15-gene hypoxia classifier in head and neck cancer for prospective use in clinical trials","volume":"55","author":"Toustrup","year":"2016","journal-title":"Acta Oncol."},{"key":"10.1016\/j.canlet.2026.218373_bib147","doi-asserted-by":"crossref","first-page":"I90","DOI":"10.1093\/jrr\/rrw007","article-title":"The impact of hypoxia and its modification of the outcome of radiotherapy","volume":"57","author":"Horsman","year":"2016","journal-title":"J. Radiat. Res."},{"key":"10.1016\/j.canlet.2026.218373_bib148","first-page":"6449","article-title":"Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review","volume":"49","author":"Vaupel","year":"1989","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218373_bib149","doi-asserted-by":"crossref","first-page":"5923","DOI":"10.1158\/0008-5472.CAN-11-1182","article-title":"Development of a hypoxia gene expression classifier with predictive impact for hypoxic modification of radiotherapy in head and neck cancer","volume":"71","author":"Toustrup","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218373_bib151","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/ars.2013.5759","article-title":"Imaging tumor hypoxia to advance radiation oncology","volume":"21","author":"Lee","year":"2014","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.canlet.2026.218373_bib152","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/mrm.30473","article-title":"Accelerated EPR imaging using deep learning denoising","volume":"94","author":"Canavesi","year":"2025","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.canlet.2026.218373_bib153","article-title":"Absolute oxygen-guided radiation therapy improves tumor control in three preclinical tumor models","volume":"10","author":"Gertsenshteyn","year":"2023","journal-title":"Front. Med."},{"key":"10.1016\/j.canlet.2026.218373_bib154","doi-asserted-by":"crossref","DOI":"10.1002\/nbm.4783","article-title":"Continuous monitoring of postirradiation reoxygenation and cycling hypoxia using electron paramagnetic resonance imaging","volume":"35","author":"Kawai","year":"2022","journal-title":"NMR Biomed."},{"key":"10.1016\/j.canlet.2026.218373_bib155","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s11307-023-01855-0","article-title":"Evaluating Tumor Hypoxia radiosensitization via Electron Paramagnetic Resonance Oxygen Imaging (EPROI)","volume":"26","author":"Rickard","year":"2024","journal-title":"Mol. Imag. Biol."},{"key":"10.1016\/j.canlet.2026.218373_bib156","doi-asserted-by":"crossref","first-page":"5620","DOI":"10.1158\/1078-0432.CCR-24-1170","article-title":"Oxygen-enhanced MRI detects incidence, onset, and heterogeneity of radiation-induced hypoxia modification in HPV-associated oropharyngeal cancer","volume":"30","author":"Dubec","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218373_bib157","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1158\/2767-9764.CRC-24-0315","article-title":"Combined oxygen-enhanced MRI and perfusion imaging detect hypoxia modification from banoxantrone and atovaquone and track their differential mechanisms of action","volume":"4","author":"O'Connor","year":"2024","journal-title":"Cancer Res. Commun."},{"key":"10.1016\/j.canlet.2026.218373_bib158","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.1158\/1078-0432.CCR-16-1209","article-title":"Noninvasive imaging of cycling hypoxia in head and neck cancer using intrinsic susceptibility MRI","volume":"23","author":"Panek","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218373_bib159","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1158\/1078-0432.CCR-18-3932","article-title":"Oxygen-enhanced MRI is feasible, repeatable, and detects radiotherapy-induced change in hypoxia in xenograft models and in patients with non-small cell lung cancer","volume":"25","author":"Salem","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218373_bib160","first-page":"24","article-title":"Value of blood oxygenation level-dependent magnetic resonance imaging in early evaluation of the response and prognosis of esophageal squamous cell carcinoma treated with definitive chemoradiotherapy: a preliminary study","author":"Zheng","year":"2024","journal-title":"BMC Med. Imag."},{"key":"10.1016\/j.canlet.2026.218373_bib161","doi-asserted-by":"crossref","DOI":"10.1002\/nbm.70104","article-title":"Quantification of oxygenation and oxygen consumption rates in the mouse brain based on tissue oxygen level-dependent (TOLD) MRI","volume":"38","author":"Parajuli","year":"2025","journal-title":"NMR Biomed."},{"key":"10.1016\/j.canlet.2026.218373_bib162","first-page":"335","article-title":"Three-dimensional arterial spin labeling-guided dose painting radiotherapy for non-enhancing low-grade gliomas","volume":"41","author":"Zhu","year":"2023","journal-title":"Jpn. J. Radiol."},{"key":"10.1016\/j.canlet.2026.218373_bib163","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/RLI.0000000000001127","article-title":"A comprehensive and repeatable contrast-enhanced ultrasound quantification approach for clinical evaluations of tumor blood flow","volume":"60","author":"Krolak","year":"2025","journal-title":"Investig. Radiol."},{"key":"10.1016\/j.canlet.2026.218373_bib164","doi-asserted-by":"crossref","DOI":"10.1038\/1981275a0","article-title":"Intrinsic non-protein sulphydryl levels and cellular radiosensitivity","volume":"198","author":"Revesz","year":"1963","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218373_bib165","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/187861a0","article-title":"Chromosome ploidy and radiosensitivity of tumours","volume":"187","author":"Revesz","year":"1960","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218373_bib166","article-title":"Relationship between chromosome ploidy and radiosensitivity in selected tumor sublines of common origin","volume":"25","author":"Revesz","year":"1960","journal-title":"Jnci-Journal of the National Cancer Institute"},{"key":"10.1016\/j.canlet.2026.218373_bib167","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15051420","article-title":"Isogenic cell lines derived from specific organ metastases exhibit divergent cytogenomic aberrations","volume":"15","author":"Winnard","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2026.218373_bib168","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0242384","article-title":"Divergent organ-specific isogenic metastatic cell lines identified using multi-omics exhibit differential drug sensitivity","volume":"15","author":"Winnard","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2026.218373_bib169","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20160474","article-title":"The changing paradigm of tumour response to irradiation","volume":"90","author":"Hill","year":"2017","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.canlet.2026.218373_bib170","first-page":"871","article-title":"Effects of combinations of antileukemic agents on an acute lymphocytic leukemia of mice","volume":"12","author":"Law","year":"1952","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218373_bib171","first-page":"698","article-title":"Differences between cancers in terms of evolution of drug resistance","volume":"16","author":"Law","year":"1956","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218373_bib172","first-page":"15","article-title":"Consolidative radiotherapy after complete remission following R-CHOP immunochemotherapy in stage III-IV diffuse large B-Cell lymphoma patients: a systematic review and meta-analysis","author":"Choi","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2026.218373_bib173","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/21556660.2022.2073101","article-title":"A review of the risks of long-term consequences associated with components of the CHOP chemotherapy regimen","volume":"11","author":"Watson","year":"2022","journal-title":"Journal of Drug Assessment"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526001369?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526001369?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T12:12:24Z","timestamp":1777551144000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526001369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":178,"alternative-id":["S0304383526001369"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218373","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A longitudinal analysis of radiosensitizer development in cancer therapy","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218373","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"218373"}}